Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma
NCT03466450
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
PF-04449913
DRUG:
Temozolomide Oral Capsule
Sponsor
Grupo Español de Investigación en Neurooncología